• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Lifevantage Corp

+ Add to Watchlist

L2T:GR

0.929 EUR 0.032 3.33%

As of 02:00:11 ET on 08/28/2014.

Snapshot for Lifevantage Corp (L2T)

Open: 0.929 Day's Range: 0.929 - 0.929 Volume: 0
Previous Close: 0.961 52wk Range: 0.886 - 1.864 1-Yr Rtn: -46.88%

Stock Chart for L2T

No chart data available.
  • L2T:GR 0.929
  • 1D
  • 1M
  • 1Y
0.961
Interactive L2T Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for L2T

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) 11.6567
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (06/2014) 0.1050
Est. PEG Ratio 0.9714
Market Cap (M EUR) 96.34
Shares Outstanding (M) 103.70
30 Day Average Volume 100
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/10/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for L2T

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for L2T

Lifevantage Corporation is a health and nutrition company that develops dietary supplements. The Company produces nutritional products that are intended to combat oxidative stress to support brain, eye and joint function as well as skin canine products.

Douglas C Robinson "Doug"President/CEODavid ColbertCFO/Treasurer
Robert UrbanChief Operating OfficerDavid TodaChief Marketing Officer
More Company Profile & Key Executives for L2T

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil